SynthesisOrphanet journal of rare diseases2021

Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials.

Enyao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.